Compare Mesoblast Limited (MESO) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Reddit Inc — how do they compare? Mesoblast Limited trades at $16.86 (market cap $2.21B), while Reddit Inc trades at $153.81 (market cap $30.05B). The key difference: Reddit Inc is far larger — about 13.6× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| MESO | RDDT | |
|---|---|---|
Market Cap | $2.21B | $30.05B |
Sector | Technology | Media |
52-Week High | $20.96 | $270.71 |
52-Week Low | $12.88 | $121.84 |
Enterprise Value | $2.21B | $27.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.9, up 1.32% on the day, with a bullish technical signal from moving averages. The company reported Ryoncil net revenues of $36 million for the quarter ended June 30, 2026, and achieved its target of 300 patients in a Phase 3 trial for chronic low back pain. Despite strong revenue growth from its commercial launch, fundamentals show a net income margin of -144.33% and negative EBITDA of $80.06 million for 2025, reflecting significant losses amid expansion.
The outlook hinges on commercial execution and regulatory progress, with analyst consensus leaning buy (45% buy ratings). Key risks include high cash burn, dependence on pipeline success, and competitive pressures. Upside potential exists if revenue growth accelerates and losses narrow, but investors face volatility from clinical trial outcomes and funding needs.
Reddit (RDDT) trades at $152.50, down 3.91% amid a bearish technical signal despite strong Q2 2026 results showing 61% revenue growth and earnings beats. The stock faces selling pressure despite analyst consensus of $220.25 price target and 64% buy ratings. Recent CEO share sales and search traffic concerns have weighed on sentiment, though fundamentals remain robust with 31.35% net margins and positive cash flow trends.
The outlook remains bifurcated with strong fundamental performance contrasting with technical weakness. Investment opportunity lies in discounted valuation post-selloff and AI monetization potential, while risks include user growth sustainability and competitive pressures in social media landscape. The stock presents a growth-at-reasonable-price case if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
